General Information of the Compound
| Compound ID |
CP0725692
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
((1S,5S)-3-(9-((R)-2-hydroxy-2-(4-hydroxy-3-(methylsulfonamido)phenyl)ethylamino)nonyl)-3-azabicyclo[3.1.0]hexan-1-yl)methyl 3'-chloro-4'-hydroxybiphenyl-2-ylcarbamate
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C37H49ClN4O7S
|
||||||||||||||||||
| Molecular Weight |
729.34
|
||||||||||||||||||
| Canonical SMILES |
CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2C[C@H]3C[C@@]3(COC(=O)Nc3ccccc3-c3ccc(O)c(Cl)c3)C2)ccc1O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C37H49ClN4O7S/c1-50(47,48)41-32-20-27(14-16-34(32)44)35(45)22-39-17-9-5-3-2-4-6-10-18-42-23-28-21-37(28,24-42)25-49-36(46)40-31-12-8-7-11-29(31)26-13-15-33(43)30(38)19-26/h7-8,11-16,19-20,28,35,39,41,43-45H,2-6,9-10,17-18,21-25H2,1H3,(H,40,46)/t28-,35+,37+/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
GHEXUPCRJJWFHU-FNNIOBQYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound